Post Job

RQM main competitors are Onyx Pharmaceuticals, PacBio, and Amicus Therapeutics.

Competitor Summary. See how RQM compares to its main competitors:

  • Medimmune has the most employees (6,030).
  • Employees at Onyx Pharmaceuticals earn more than most of the competitors, with an average yearly salary of $95,378.
Work At RQM?
Share Your Experience

RQM vs competitors

CompanyFounding DateZippia ScoreHeadquarters# of LocationsRevenueEmployees
2008
3.7
Monroeville, PA1$15.4M405
1988
4.9
Bridgewater, NJ1$363.7M373
1997
4.6
San Rafael, CA4$2.9B2,581
1996
4.8
Silver Spring, MD6$2.9B950
1992
4.8
South San Francisco, CA2$362.2M500
-
4.1
Norcross, GA1$11.0M99
1987
4.7
Gaithersburg, MD1$422.2M6,030
1995
4.7
Austin, TX3$417.4M1,140
Medical Device Company
-
4.5
----
2002
4.6
Cranbury, NJ2$528.3M508
2004
4.7
Menlo Park, CA1$154.0M400
1995
4.5
Hopkinton, MA1$109.8M200
1986
4.2
Incline Village, NV1$30.7M75
1994
4.1
Sunnyvale, CA1-3,000

Rate how well RQM differentiates itself from its competitors.

Zippia waving zebra

RQM salaries vs Competitors

Among RQM competitors, employees at Onyx Pharmaceuticals earn the most with an average yearly salary of $95,378.

Compare RQM Salaries VS Competitors

CompanyAverage SalaryHourly SalarySalary Score
RQM
$73,114$35.15-
Insmed
$81,784$39.32-
BioMarin
$87,259$41.95-
United Therapeutics
$74,314$35.73-
Onyx Pharmaceuticals
$95,378$45.85-
BEST VASCULAR
$57,197$27.50-

Compare RQM Job Title Salaries VS Competitors

CompanyHighest SalaryHourly Salary
RQM
$77,910$37.46
Onyx Pharmaceuticals
$107,304$51.59
BioMarin
$98,152$47.19
Medimmune
$93,132$44.78
BEST VASCULAR
$88,194$42.40
Medical Device Company
$87,532$42.08
Luminex
$86,388$41.53
Caliper Life Sciences
$84,888$40.81
Insmed
$80,649$38.77
Kyphon
$79,384$38.17
United Therapeutics
$78,439$37.71
PDL BioPharma
$73,712$35.44
Amicus Therapeutics
$69,554$33.44
PacBio
$62,499$30.05

Do you work at RQM?

Is RQM able to compete effectively with similar companies?

RQM Jobs

RQM demographics vs competitors

Compare Gender At RQM Vs Competitors

Job TitleMaleFemale
Amicus Therapeutics43%57%
PDL BioPharma46%54%
BioMarin50%50%
Luminex59%41%
PacBio65%35%
RQM--
Male
Female

Compare Race At RQM Vs Competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity Score
47%17%9%21%6%
8.8
43%20%8%23%7%
9.6
48%23%11%14%3%
9.8
42%20%5%27%5%
9.6
54%15%7%19%4%
9.3
55%10%18%12%5%
9.5

RQM And Similar Companies CEOs

CEOBio
John Francis Crowley
Amicus Therapeutics

John Francis Crowley (born April 7, 1967) is an American biotechnology executive and entrepreneur and the chairman and CEO of Amicus Therapeutics. He co-founded Novazyme Pharmaceuticals with William Canfield, which was later acquired by Genzyme Corporation, and founded Orexigen Therapeutics. In 2006, he was profiled in the book The Cure: How a Father Raised $100 Million – And Bucked the Medical Establishment – In a Quest to Save His Children by Geeta Anand. In 2010, Crowley released his memoir, Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy. Crowley and his family were the inspiration for the movie Extraordinary Measures starring Harrison Ford and Brendan Fraser in 2010.

Jean Jacques Bienaime
BioMarin

Jean-Jacques Bienaime is a Board Member at Biotechnology Innovation Organization - BIO, Director at INCYTE CORP, and Chairman/CEO at BioMarin Pharmaceutical Inc and is based in Novato, California. He has experience at Rhône Poulenc Rorer and has worked as President/CEO at GENENCOR INTERNATIONAL INC, Board Member at NeurogesX Inc, and Marketing Director at Genentech. Jean attended ESCP Europe, Ecole Superieure de Commerce de Paris between 1974 and 1976, and University of Pennsylvania.

William H. Lewis J.d
Insmed

Nachum Shamir
Luminex

With a proven track record of bringing game-changing technologies to the market, Mr. Shamir joined Luminex Corporation as President, Chief Executive Officer, and Board Member in 2014. From 2006 to 2014, Mr. Shamir served as President and CEO of Given Imaging, a developer, manufacturer, and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract, which was acquired by Covidien PLC in early 2014. Mr. Shamir currently serves on the board of directors of Exalenz Bioscience Ltd. (TASE: EXEN). He has previously served as a Board Member at Scitex Corporation, Cogentix Medical (NASDAQ: CGNT), recently acquired by Laborie Medical Technologies, and invendo medical GmBH, now part of Ambu. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.

Christian O. Henry
PacBio

Christopher Stone
PDL BioPharma

Martine A. Rothblatt Ph.D., Mba
United Therapeutics

Founder of Sirius XM radio and United Therapeutics. Progressive technologist and green energy advocate. Helicopter, fixed wing pilot.

Speck Loe
Medimmune

Speck Loe works at Medimmune and a Ceo at Medimmune and is based in Granite Falls, Washington.

Richard Mott (Rich)
Kyphon

Richard 'Rich' Mott is a Chairman at Conventus Orthopaedics Inc, President/CEO at Kyphon, and Board Member at Vertiflex. He has worked as Board Member at Alfred University, Board Member at Conventus Orthopaedics Inc, and VP/General Manager at Greatbatch Scientific. Richard attended Alfred University and Harvard University.

RQM Competitors FAQs

Search for jobs